Applied Therapeutics shareholders approve reverse stock split (1:5 to 1:40) at 2025 annual meeting

Applied Therapeutics, Inc.

Stockholders elected Teena Lerner as Class III director with 44,287,976 votes for, until 2028.
Ratified Ernst & Young as independent auditor for FY2025: 99,429,280 votes for.
Advisory say-on-pay approved with 57,650,206 votes for; future votes set every 1 year.
Approved reverse stock split at ratio 1:5 to 1:40 (board discretion) with 92,238,511 votes for, 8,537,480 against.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.